This study provides insights into the post-transcriptional regulatory mechanisms of PrPc and emphasizes miR-193b-3p as a potential therapeutic agent for mitigating lung cancer invasiveness and metastasis. The gene discussed is PRNP; the disease is lung carcinoma.